Insomnia Insomnia

186 Attarian
residual sedation following middle-of-the-night zaleplon administration in sleep maintenance
insomnia. Clin. Neuropharmacol. 23(1), 17–21.
48. Quera-Salva, M. A., Philip, P., Taillard, J., et al. (2002) [Study of the real situation of improvement
by Zopiclone in treatment of insomnia among persons working during night shifts]. Rev.
Neurol. (Paris) 158(11), 1102–1106.
49. Hajak, G., Bardelow, B., Zulley, J., and Pittrow, D. (2002) “As needed” pharmacotherapy combined
with stimulus control treatment in chronic insomnia—assessment of a novel intervention
strategy in a primary care setting. Ann. Clin. Psychiatry 14(1), 1–7.
50. Hajak, G., Cluydts, R., Dederck, A., et al. (2002) Continuous versus non-nightly use of zolpidem
in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study. Int.
Clin. Psychopharmacol. 17(1), 9–17.
51. Becker, P. M., Ondo, W., and Sharon, D. (1998) Encouraging initial response of restless legs
syndrome to pramipexole. Neurology 51(4), 1221–1223.
52. Lin, S. C., kaplan, J., Burger, C., D., and Fredrickson, P. A. (1998) Effect of pramipexole in
treatment of resistant restless legs syndrome. Mayo Clin. Proc. 73(6), 497–500.
53. Saletu, B., Gruber, G., Saletu, B., et al. (2000) Sleep laboratory studies in restless legs syndrome
patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and
subjective sleep and awakening quality. Neuropsychobiology 41(4), 181–189.
54. Saletu, M., Anderer, P., Saletu, B., et al. (2000) Sleep laboratory studies in restless legs syndrome
patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg
movements, arousals and respiratory variables. Neuropsychobiology 41(4), 190–199.
55. Wetter, T. C., Stjasny, K., Winkelmann, J., et al. (1999) A randomized controlled study of
pergolide in patients with restless legs syndrome. Neurology 52(5), 944–950.
56. Brodeur, C., Montplaisir, J., Godbout, R., and Mariner, R. (1998) Treatment of restless legs syndrome
and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology
38(12), 1845–1848.
57. Walters, A. S., Wagner, M. L., Hening, W, A,, et al. (1993) Successful treatment of the idiopathic
restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep
16(4), 327–332.
58. Peled, R. and Lavie, P. (1987) Double-blind evaluation of clonazepam on periodic leg movements
in sleep. J. Neurol. Neurosurg. Psychiatry 50(12), 1679–1681.
59. Happe, S., Klosch, G., Saletu, B., and Zeitlhofer, J. (2000) Treatment of idiopathic restless legs
syndrome (RLS) with gabapentin. Neurology 57(9), 1717–1719.
60. Garcia-Borreguero, D., Larrosa, O., de la Llave, Y., Verger, K., Masramon, X., and Hernandez G.
(2002) Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.
Neurology 59(10), 1573–1579.
61. Wagner, M. L., Walters, A. S., Coleman, R. G., Hening, W. A., Grasing, K., and Chokroverty, S.
(1996) Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome.
Sleep 19(1), 52–58.
62. Moe, K. E. (1999) Reproductive hormones, aging, and sleep. Semin. Reprod. Endocrinol. 17(4),
339–348.
63. Polo-Kantola, P., Erkkola, R., Irjala, K., Pullinen, S., Virtanen, I., and Polo, O. (1999) Effect of
short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover
trial in postmenopausal women. Fertil. Steril. 71(5), 873–880.
64. Mahady, G. B., Fabricant, D., Chadurch, L. R., and Diets, B. (2002) Black cohosh: an alternative
therapy for menopause? Nutr. Clin. Care 5(6), 283–289.